Estimating median overall survival of apalutamide compared to placebo in metastatic hormone-sensitive prostate cancer (mHSPC) populations: Statistical extrapolations of the TITAN study
Agarwal, Neeraj, Bjartell, Anders, Juárez, Álvaro, Kerßenboom, Ronja, Perualila, Nolen, Wigfield, Peter, Chi, Kim N.
Published in Journal of clinical oncology (01.02.2024)
Published in Journal of clinical oncology (01.02.2024)
Get full text
Journal Article
A MEA is a MEA is a MEA? Sequential decision making and the impact of different managed entry agreements at the manufacturer and payer level, using a case study for an oncology drug in England
Buyukkaramikli, Nasuh C., Wigfield, Peter, Hoang, Men Thi
Published in The European journal of health economics (01.02.2021)
Published in The European journal of health economics (01.02.2021)
Get full text
Journal Article
Are Published Health Economic Models for Chronic Hepatitis B Appropriately Capturing the Benefits of HBsAg Loss? A Systematic Literature Review
Wigfield, Peter, Sbarigia, Urbano, Hashim, Mahmoud, Vincken, Talitha, Heeg, Bart
Published in PharmacoEconomics - open (01.09.2020)
Published in PharmacoEconomics - open (01.09.2020)
Get full text
Journal Article
A comparative network meta-analysis of standard of care treatments in treatment-naïve chronic hepatitis B patients
Sbarigia, Urbano, Vincken, Talitha, Wigfield, Peter, Hashim, Mahmoud, Heeg, Bart, Postma, Maarten
Published in Journal of comparative effectiveness research (01.10.2020)
Published in Journal of comparative effectiveness research (01.10.2020)
Get full text
Journal Article
How are Companion Diagnostics Considered in Economic Evaluations of Oncology Treatments? A Review of Health Technology Assessments
Gomez Montero, Melissa, El Alili, Houcine, Hashim, Mahmoud, Wigfield, Peter, Dimova, Mariya, Riley, Ralph, Pascoe, Katie
Published in PharmacoEconomics - open (01.09.2022)
Published in PharmacoEconomics - open (01.09.2022)
Get full text
Journal Article